These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 7423987)

  • 1. [The crythrocyte system in terminal renal failure caused by chronic glomerulonephritis, treated by hemodialysis].
    Dobiecka-Wawrzecka B
    Wiad Lek; 1980 Jun; 33(11):849-54. PubMed ID: 7423987
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glyceraldehydephosphate dehydrogenase activity in the erythrocytes of patients with terminal chronic renal failure treated with repeated dialysis].
    Kopczyński Z; Chmiel J; Dryl T; Czarnecki R
    Pol Tyg Lek; 1982 Oct; 37(39):1157-9. PubMed ID: 7163058
    [No Abstract]   [Full Text] [Related]  

  • 3. [Activity of plasma renin in patients with terminal renal insufficiency kept on chronic hemodialysis].
    Lifshits NL; Ermolenko VM; Sumarokov AV; Tatsievskiĭ VA; Kondakhchan MA
    Ter Arkh; 1975; 47(4):81-8. PubMed ID: 1145487
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sodium and potassium content of erythrocytes at the terminal stage of chronic renal insufficiency and during treatment by chronic hemodialysis].
    Terekhov NT; Goligorskiĭ MS; Kremen' MG; Vasilenko VK
    Urol Nefrol (Mosk); 1974; (6):10-4. PubMed ID: 4141153
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of programmed hemodialysis on the absorptive-excretory function of the liver in terminal chronic renal insufficiency].
    Kozyr' VI
    Vrach Delo; 1975 Jun; (6):41-3. PubMed ID: 1154735
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship between carbonic anhydrases and zinc concentration of erythrocytes in patients under chronic hemodialysis.
    Goriki K; Wada K; Hata J; Kobayashi M; Hirabayashi A; Shigemoto K; Hamaguchi N; Yorioka N; Yamakido M
    Hiroshima J Med Sci; 1982 Jun; 31(2):123-7. PubMed ID: 6813298
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of dialysis membranes on lipid peroxidation in erythrocytes of patients with terminal renal failure].
    Kubatiev AA; Rud'ko IA; Balashova TS; Ermolenko VM
    Biull Eksp Biol Med; 1994 Nov; 118(11):460-2. PubMed ID: 7888639
    [No Abstract]   [Full Text] [Related]  

  • 8. [Peritoneal dialysis in the treatment of chronic renal failure].
    Kazimirov VG; Butrin SV; Bekov RR; Sapozhnikov AD; Kharitonov BI; Smoliakov AM; Detinenko IN
    Urologiia; 2004; (5):58-62. PubMed ID: 15560166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The mechanisms of the development of arterial hypertension in patients with chronic kidney failure treated by hemodialysis].
    Konstantinov IuV; Komandenko MS; Nikolaeva AA; D'iachuk MM
    Urol Nefrol (Mosk); 1993; (3):39-41. PubMed ID: 7941161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intermittent hemodialysis in terminal chronic nephropathy in Fredericia Hospital].
    Birkeland SA; Hoffmeyer J; Rojel J
    Ugeskr Laeger; 1969 Mar; 131(12):511-9. PubMed ID: 5793607
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of recombinant human erythropoietin on the rate of Na+,H+-exchange in erythrocytes of patients with chronic kidney insufficiency treated by hemodialysis].
    Kubatiev AA; Rud'ko IA; Ermolenko VM
    Biull Eksp Biol Med; 1997 Dec; 124(12):613-5. PubMed ID: 9483309
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thiamine penetration into erythrocytes of patients with chronic renal failure treated with repeated dialyses].
    Kopczyński Z; Chmiel J; Baczyk K; Czarnecki R
    Pol Tyg Lek; 1982 Mar; 37(1):13-5. PubMed ID: 7111064
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of hemodialysis on the cyclic nucleotide content of thrombocytes in patients with chronic kidney failure].
    Rud'ko IA; Kulakov GP; Kubatiev AA
    Urol Nefrol (Mosk); 1987; (5):47-50. PubMed ID: 3424469
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of hemodialysis on the level of cytoplasmic Ca2+ in the thrombocytes of patients with chronic kidney failure].
    Rud'ko IA; Kubatiev AA; Tsalenchuk IaP
    Urol Nefrol (Mosk); 1993; (4):37-9. PubMed ID: 8310566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of intermittent hemodialysis in the treatment of terminal cases of chronic renal failure].
    Pintér J
    Orv Hetil; 1967 Dec; 108(53):2497-500. PubMed ID: 4872892
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in myocardial contractile function in kidney failure patients treated by programmed hemodialysis].
    Shvaro SV
    Vrach Delo; 1981 Sep; (9):79-82. PubMed ID: 7303622
    [No Abstract]   [Full Text] [Related]  

  • 17. [Optimization of the method of chronic hemodialysis].
    Zeĭdlits LA; Shcherbakova EO; Verkhovskiĭ BD; Ivanova EIa; Smagina LP
    Ter Arkh; 1978; 50(6):122-6. PubMed ID: 675530
    [No Abstract]   [Full Text] [Related]  

  • 18. Levels of serum glycosaminoglycans in renal failure.
    Mitsuhashi M; Mitsuhashi H; Yano S; Tsukada Y; Nojima Y; Naruse T
    Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):225-32. PubMed ID: 9583096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of tap water on the level of plasma magnesium in patients with terminal stage of chronic renal insufficiency treated by hemodialysis].
    Bazhanova IM; Levitskiĭ ER
    Urol Nefrol (Mosk); 1975; (1):35-8. PubMed ID: 1118971
    [No Abstract]   [Full Text] [Related]  

  • 20. [The nature of the humoral hemolytic factors in patients with chronic kidney failure].
    Ershova LI; Gorbunova NA
    Ter Arkh; 1997; 69(7):46-50. PubMed ID: 9424758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.